Huang J, Zhu J, Zhong Q, Guo F, Lin Y, Zhang Z
Front Oncol. 2024; 14:1447393.
PMID: 39257555
PMC: 11385285.
DOI: 10.3389/fonc.2024.1447393.
Wu Z, Wu C, Zhao J, Wu C, Peng H, Wang Q
EClinicalMedicine. 2024; 71:102579.
PMID: 38618203
PMC: 11015339.
DOI: 10.1016/j.eclinm.2024.102579.
Xie L, Zhang Z
Front Immunol. 2024; 15:1334992.
PMID: 38292873
PMC: 10825045.
DOI: 10.3389/fimmu.2024.1334992.
Ao Y, Zhong L, Luo K, Li S, Zhang X, Shao L
Ann Surg Oncol. 2024; 31(6):3830-3838.
PMID: 38245649
DOI: 10.1245/s10434-024-14937-2.
Zhu Y, Xu S, Teng X, Zhao R, Peng L, Fang Q
Esophagus. 2023; 21(2):141-149.
PMID: 38133841
DOI: 10.1007/s10388-023-01036-6.
Clinical value of station 4R node dissection in esophageal squamous cell carcinoma.
Wang X, Fu X, Yang H, Wen J, Lin P, Fu J
World J Surg Oncol. 2023; 21(1):387.
PMID: 38110961
PMC: 10726609.
DOI: 10.1186/s12957-023-03280-7.
Diagnostic value of conventional endoscopic ultrasound for lymph node metastasis in upper gastrointestinal neoplasia: A meta-analysis.
Chen C, Song Y, Wu Z, Chen J, Zhang Y, Chen L
World J Gastroenterol. 2023; 29(30):4685-4700.
PMID: 37662859
PMC: 10472901.
DOI: 10.3748/wjg.v29.i30.4685.
Pre-immunotherapy radiotherapy enhanced the efficacy of multi-line sintilimab in unresectable advanced esophageal squamous cell carcinoma.
Xu S, Xu X, Zhu H
Front Immunol. 2023; 14:960339.
PMID: 36891294
PMC: 9986250.
DOI: 10.3389/fimmu.2023.960339.
Thoracic para-aortic lymph node recurrence in patients with esophageal squamous cell carcinoma: A propensity score-matching analysis.
Li X, Huang L, Yu S, Xie D
World J Clin Cases. 2023; 10(36):13313-13320.
PMID: 36683614
PMC: 9851007.
DOI: 10.12998/wjcc.v10.i36.13313.
Correlation between immune-related adverse events and treatment efficacy of anti-PD1 immunotherapy in patients with esophageal squamous cell carcinoma.
Cao R, Wu C, Lv Y, Xu S, Li C, Yin F
Oncol Lett. 2023; 25(2):55.
PMID: 36644142
PMC: 9827461.
DOI: 10.3892/ol.2022.13641.
The development of a nomogram model for predicting left recurrent laryngeal nerve lymph node metastasis in esophageal cancer based on radiomics and clinical factors.
Huang Y, Yan C, Lin X, Chen Z, Lin F, Feng Z
Ann Transl Med. 2023; 10(23):1282.
PMID: 36618793
PMC: 9816832.
DOI: 10.21037/atm-22-5628.
The Clinical Application Value of the Prognostic Nutritional Index for the Overall Survival Prognosis of Patients with Esophageal Cancer: A Robust Real-World Observational Study in China.
Kang J, Yang G, Wang D, Lin Y, Wang Q, Luo H
Comput Math Methods Med. 2022; 2022:3889588.
PMID: 35872955
PMC: 9300322.
DOI: 10.1155/2022/3889588.
Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development.
Lu T, Xu R, Wang C, Zhao J, Peng B, Wang J
Front Genet. 2022; 13:853113.
PMID: 35734437
PMC: 9207414.
DOI: 10.3389/fgene.2022.853113.
Development and validation of a nomogram for prediction of cervical lymph node metastasis in middle and lower thoracic esophageal squamous cell carcinoma.
Yan Z, Xu X, Lu J, You Y, Xu J, Xu T
BMC Gastroenterol. 2022; 22(1):163.
PMID: 35369868
PMC: 8978436.
DOI: 10.1186/s12876-022-02243-8.
Distribution of esophagus flora in esophageal squamous cell carcinoma and its correlation with clinicopathological characteristics.
Hu M, Bai W, Zhao C, Wang J
Transl Cancer Res. 2022; 9(6):3973-3985.
PMID: 35117764
PMC: 8798288.
DOI: 10.21037/tcr-20-1954.
Prognostic significance of serum carcinoembryonic antigen and squamous cell carcinoma antigen in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
Hu J, Kuang P, Chen D, Chen Y, Wen Z
Transl Cancer Res. 2022; 9(4):2460-2471.
PMID: 35117605
PMC: 8799160.
DOI: 10.21037/tcr.2020.03.20.
A Retrospective Study of 52 Patients With Primary Small Cell Carcinoma of the Esophagus Treated With Radical Surgery.
Fan N, Wang Z, Huang Y, Tan Z, Yang H, Lin P
Cancer Control. 2021; 28:10732748211027147.
PMID: 34155924
PMC: 8226382.
DOI: 10.1177/10732748211027147.
Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
Chen D, Wang W, Mo J, Ren Q, Miao H, Chen Y
BMC Cancer. 2021; 21(1):145.
PMID: 33563244
PMC: 7871649.
DOI: 10.1186/s12885-021-07867-9.
Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review.
Zhang W, Wang P, Pang Q
Ann Transl Med. 2020; 8(18):1193.
PMID: 33241042
PMC: 7576075.
DOI: 10.21037/atm-20-4625.
The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma.
Zhao J, Lei T, Zhang T, Chen X, Dong J, Guan Y
Ann Transl Med. 2020; 8(18):1160.
PMID: 33241009
PMC: 7576073.
DOI: 10.21037/atm-20-4366.